Home / News

News

INVECTYS INC. TO PARTICIPATE IN THE 2021 H.C. WAINWRIGH...

Houston, Texas, USA, Sept. 07, 2021 (GLOBE NEWSWIRE) — Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the…

Read more

Invectys Inc. to participate in the 2021 Roth Virtual H...

Invectys Inc. to participate in the 2021 Roth Virtual Healthcare Private Company Forum on June 28th, 2021   Houston, TX, USA, May 4, 2021 (GLOBE NEWSWIRE) –…

Read more

Invectys nominates Rosemary Williams, CPA, as Vice-Pres...

Invectys nominates Rosemary Williams, CPA, as Vice-President for Administration and Controller Houston, TX, USA, June 1st, 2021 (GLOBE NEWSWIRE) — Invectys…

Read more

Invectys, Inc appoints Biopharma Veteran, Praveen Tyle,...

Invectys, Inc appoints Biopharma Veteran, Praveen Tyle, PhD as President & CEO   Houston, TX, USA, May 4, 2021 (GLOBE NEWSWIRE) – Invectys, Inc., a clinical-stage…

Read more

AACR Annual Meeting 2021

AACR Annual Meeting 2021 April 10th – 15th 2021   Invectys was at the AACR’s Annual Meeting 2021. Although online, the AACR Annual Meeting still carried…

Read more

Invectys’ CARGo project: $14.2M 2020 CPRIT Award

Invectys well poised to bring its anti-HLA-G CAR-T cells to clinical trials …

Read more

Invectys reports in vivo efficacy of its pan anti-tumor...

Invectys reports in vivo efficacy of its pan anti-tumor anti-HLA-G CAR-T cells These results open new perspectives in oncology for targeting cancer through HLA-G,…

Read more

Invectys : Dennis J. Purcell (Aisling Capital) join Adv...

Invectys Strengthens Advisory Board with the Appointment of Dennis J. Purcell, Life Sciences Industry Veteran and Founder of Aisling Capital LLC Paris, France, May…

Read more